Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-25-000082
Filing Date
2025-01-03
Accepted
2025-01-03 17:02:08
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4128
  Complete submission text file 0001683168-25-000082.txt   5707
Mailing Address OCULUS INNOVATIVE SCIENCES, INC. 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address
MCLAUGHLIN JOHN (Reporting) CIK: 0001203240 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33216 | Film No.: 25507555

Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Issuer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)